Axcelis Technologies Breaks Out As Shares Zip Higher; 20% Growth Expected, But There's This Flaw
Axcelis Technologies Breaks Out As Shares Zip Higher; 20% Growth Expected, But There's This Flaw
Axcelis Technologies took off following its recent earnings report in early May, hitting a buy point of a base on Wednesday, and is the IBD 50 Stocks To Watch pick.
Axcelis 科技 繼5月初發布最近的財報後起飛，週三觸及基本買入點，是IBD 50只值得關注的股票精選。
The Beverly, Mass.-based company provides spare parts, equipment upgrades and maintenance services to the semiconductor industry.
馬薩諸塞州貝弗利酒店總部位於美國的公司爲半導體行業提供備件、設備升級和維護服務。
More specifically, Axcelis Technologies produces ion implantation equipment used in the fabrication of semiconductor chips. Its products are developed and manufactured mainly in the U.S. and South Korea, and are sold in the U.S., Europe and Asia.
更具體地說，Axcelis Technologies生產用於製造半導體芯片的離子注入設備。其產品主要在美國和韓國開發和製造，並在美國、歐洲和亞洲銷售。
A high 64.7% of its March quarter revenues came from its 10 largest customers. If several big customers were to leave, it could be a revenue-impacting event.
其3月季度收入的64.7％來自其十大客戶。如果有幾個大客戶離開，那可能會影響收入。
Axcelis Technologies holds the No. 2 spot out of 29 stocks in the Electronics-Semiconductor Equipment group. The group ranks 42nd out of the 197 IBD industry groups.
在電子半導體設備集團的29只股票中，Axcelis Technologies排名第二。該集團在 197 個 IBD 行業集團中排名第 42 位。
The CAN SLIM investing strategy seeks stocks in the top 40 or higher industry groups.
CAN SLIM投資策略尋找排名前40或以上的行業羣體的股票。
Axcelis Technologies Breaks Out Of Base
Accelis科技突破了困境
Shares jumped another 4% Thursday following Wednesday's spike, as tech stocks continued to rally. Shares Thursday afternoon were slightly above the 5% buy zone, which tops out at 143.30.
由於科技股繼續上漲，週三股價飆升後，週四又上漲了4％。週四下午股價略高於5％的買入區域，最高爲143.30。
ACLS popped 6% and broke out of a cup-without-handle base on Wednesday, hitting the 136.48 buy point. Although price action was strong, volume was only about average.
週三，ACLS上漲了6％，突破了無把手的杯賽基礎，觸及136.48的買入點。儘管價格走勢強勁，但成交量僅爲平均水平。
The formation is in a desirable second-stage base, according to MarketSmith pattern recognition.
根據MarketSmith模式識別，該陣型處於理想的第二階段基礎。
The relative strength line hit a 52-week high, as shown with the blue dot on the weekly MarketSmith chart. Shares hit an all-time high Thursday, and have gained over 80% this year so far.
相對強弱線觸及52周高點，如每週MarketSmith圖表上的藍點所示。週四股價創下歷史新高，今年迄今已上漲80％以上。
The stock hit the low of the base on May 4, following volatile trading that greeted the Q1 earnings report. Results topped expectations, but the company's outlook was cautious.
在迎接第一季度財報的波動之後，該股於5月4日觸及基數的低點。業績超出預期，但該公司的前景持謹慎態度。
The stock quickly reversed course the next day, and has been on an upward trajectory ever since. Shares have gained over 25% since the earnings release.
第二天，該股迅速逆轉，此後一直處於上漲軌道。自財報發佈以來，股價已上漲了25％以上。
ACLS reclaimed the key 50-day moving average this week, as chip and tech stocks outperformed.
由於芯片和科技股跑贏大盤，ACLS本週收復了關鍵的50天移動平均線。
Earnings Beat Projections But Pace Slows
收益超出預期，但步伐放緩
Axcelis Technologies reported better-than-expected first quarter EPS and sales on May 3, after the market close. The 17% quarterly profit growth lagged the 63% and 49% growth in the prior two quarters, and triple-digit increases prior to that.
市場收盤後，Axcelis Technologies於5月3日公佈的第一季度每股收益和銷售額好於預期。17％的季度利潤增長落後於前兩個季度的63％和49％的增長，在此之前則實現了三位數的增長。
Quarterly sales growth of 25% slowed from the 29% and 30% the prior two quarters.
25％的季度銷售增長從前兩個季度的29％和30％放緩。
"Axcelis delivered strong first quarter financial performance with a new backlog record, as a result of significant demand and solid execution by the Axcelis team," said Mary Puma, president and CEO.
總裁兼首席執行官Mary Puma表示：“由於Axcelis團隊的巨大需求和穩健的執行力，Axcelis在第一季度取得了強勁的財務業績，創下了新的積壓記錄。”
Management expects revenues between $255 million and $260 million, with full-year sales of more than $1.03 billion.
管理層預計收入在2.55億美元至2.6億美元之間，全年銷售額超過10.3億美元。
Q1 gross margin rate fell to 40.9% from 44.1% in the same quarter a year earlier. The drop came primarily from a less favorable mix of system shipments.
第一季度毛利率從去年同期的44.1％降至40.9％。下降的主要原因是系統出貨量組合不太樂觀。
Management projects 42% gross margin for Q2, and 44% for full-year 2023, up slightly from the 43.7% in 2022.
管理層預計第二季度的毛利率爲42％，2023年全年爲44％，略高於2022年的43.7％。
Analysts expect 20% full-year earnings growth this year, and 17% next year; that's on top of the nearly 90% growth in 2022.
分析師預計，今年全年收益將增長20％，明年將增長17％；這是在2022年近90％的增長基礎上進行的。
Mutual Funds Support Stock; ACLS Earns Accolades
共同基金支持股票；ACLS 獲得讚譽
Mutual funds own 58% of shares, with 573 holding the stock in March, up from 515 in December.
共同基金擁有58％的股份，3月份有573人持有該股，高於12月的515份。
Two funds in the IBD Mutual Fund Index increased their holdings in ACLS shares in the March quarter. Columbia Small-Cap Index/Institutional (CXXRX) added 280,000 shares, and it is a top holding. Invesco Discovery Fund A (OPOCX) added 260,000 shares.
IBD共同基金指數中的兩隻基金在3月份的季度增加了對ACLS股票的持有量。哥倫比亞小盤股指數/機構（CXXRX）增加了28萬股，是頭號持股。景順探索基金A（OPOCX）增加了26萬股。
Axcelis Technologies earned a place on the 2022 Fortune 100 Fastest Growing Companies. In addition, it landed on the 2022 Forbes Best Mid-Size Companies list.
Axcelis Technologies在2022年財富100強增長最快的公司中獲得了一席之地此外，它還登上了2022年福布斯最佳中型公司名單。
Follow Kimberley Koenig for more stock news on Twitter @IBD_KKoenig.
在 Twitter 上關注 Kimberley Koenig 瞭解更多股票新聞 @IBD_KKoenig。
YOU MAY ALSO LIKE:
你可能還喜歡：
Get Free IBD Newsletters: Market Prep | Tech Report | How To Invest
免費獲取 IBD 時事通訊：市場準備 | 技術報告 | 如何投資
What Is CAN SLIM? If You Want To Find Winning Stocks, Better Know It
甚麼是 CAN SLIM？如果你想找到獲勝的股票，最好知道了
IBD Live: Learn And Analyze Growth Stocks With The Pros
IBD Live：與專業人士一起學習和分析成長型股票
Looking For The Next Big Stock Market Winners? Start With These 3 Steps
尋找下一個股市大贏家？從這 3 個步驟開始
Want More IBD Insights? Subscribe To Our Investing Podcast
想了解更多 IBD 見解嗎？訂閱我們的投資播客
譯文內容由第三人軟體翻譯。